Report overview
Allergy to cats and dogs is extremely common and occurs in up to 25% of people with allergies. Cat allergies are twice as common as dog allergies. Cat allergens are produced in large amounts, particularly by male non-neutered cats. The allergens are partially under hormonal control. Cats produce a protein known as Fel d 1, which is allergenic to human beings when it is infected with bacteria or viruses. The infected protein is contained in a pet?s urine, saliva, and skin. The dead skin of pets known as dander is regularly sloughed off and replaced by new skin cells. The dander can flake off from a pet?s fur and become airborne. It can be carried on the clothing of people who have pets such as cats and dogs and then shed in public places. Therefore, pet allergens especially that of cats and dogs, are a component of house dust even in homes where cats and dogs have never lived.
This report aims to provide a comprehensive presentation of the global market for Pet Allergy Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Allergy Treatment Drugs. This report contains market size and forecasts of Pet Allergy Treatment Drugs in global, including the following market information:
Global Pet Allergy Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pet Allergy Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antihistamines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pet Allergy Treatment Drugs include Sunovion Pharmaceuticals Inc, Allergon AB, AbbVie(Allergan), HAL Allergy Group, Allergy Therapeutics, Teva Pharmaceutical, Viatris, GlaxoSmithKline and Stallergenes Greer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pet Allergy Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Allergy Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pet Allergy Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Antihistamines
Decongestants
Corticosteroid
Others
Global Pet Allergy Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pet Allergy Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Others
Global Pet Allergy Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pet Allergy Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Allergy Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pet Allergy Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sunovion Pharmaceuticals Inc
Allergon AB
AbbVie(Allergan)
HAL Allergy Group
Allergy Therapeutics
Teva Pharmaceutical
Viatris
GlaxoSmithKline
Stallergenes Greer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Allergy Treatment Drugs, market overview.
Chapter 2: Global Pet Allergy Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Pet Allergy Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Allergy Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
